Breast Cancer Clinical Trial
Official title:
Facilitating Caring Communication for People With Cancer: The Case of Breast Cancer
RATIONALE: An education program based on patients' health communication needs may improve
patients' overall healthcare experience and sense of control.
PURPOSE: This clinical trial is studying the health communication needs of patients with
breast cancer to develop patient education programs.
OBJECTIVES:
- Determine patients' health communication needs during the first 6 months of care by
interviewing patients with breast cancer (as well as their families, caregivers, and
healthcare teams) and observing interactions between patients and oncologists
throughout the trajectory of care from initial diagnosis through the initial treatment
course.
- Determine patients' health communication needs at the point of bone metastases by
interviewing patients with breast cancer (as well as their families, caregivers, and
healthcare teams) and observing interactions between patients and oncologists in the
Hematology-Oncology Clinic.
- Develop Patient Education Programs to help meet patients' health communication needs by
conveying information about essential elements of cancer care in a clear and consistent
manner, thus allowing clinicians to focus more attention on answering questions,
engaging in counseling, and responding to emotional issues.
- Create a Patient Education Program that models effective strategies for asking
questions and expressing concerns and needs for symptom control (i.e., pain, anxiety,
depression).
- Develop Patient Narrative Videos, with women identified by their providers, to provide
members of the healthcare team with a better understanding of the patient experience
and issues that arise for patients outside the formal health care setting.
- Conduct a pilot test to determine whether the Patient Education Programs affect
patients' experience of care, sense of control, and perceptions of caring
communication, as well as knowledge, satisfaction, anxiety, depression, pain, and
self-reported health.
- Determine patient and family response to Patient Narrative Videos and healthcare team
response to Patient Narrative Videos and Patient Education Programs.
OUTLINE: This is a pilot, multicenter study.
A visit between the patient and his/her oncologist and healthcare team is videorecorded.
Patients, family members, caregivers, and healthcare team members then undergo a 10-minute
interview. Patients then undergo a 5-minute follow-up interview once every 2 weeks for 6
months. Some patients may participate in a one-time group discussion.
PROJECTED ACCRUAL: A total of 120 patients will be accrued for this study.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |